252 results on '"Røsok, Bård I."'
Search Results
2. Impact of pancreas transection site on incidence of pancreatic fistula after distal pancreatectomy: a propensity score matched study
3. Health Economic Evaluation of Patients With Colorectal Liver Metastases Randomized to ALPPS or TSH: Analysis From the LIGRO Trial
4. Laparoscopic parenchyma-sparing liver resection for large (≥ 50 mm) colorectal metastases
5. Implementation and training with laparoscopic distal pancreatectomy: 23-year experience from a high-volume center
6. Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma
7. Laparoscopic distal pancreatectomy in patients with poor physical status
8. High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases
9. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity
10. Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer
11. The expressed mutational landscape of microsatellite stable colorectal cancers
12. Response to the Comment on “ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO—Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy”
13. Response to Comment on “ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM – It Is Time to Entry the IDEAL Stage 4?”
14. Response to comment on “ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO—Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy”
15. Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: Long-term oncologic outcomes after standard resection
16. Minimally invasive pancreatoduodenectomy
17. Minimally invasive pancreatic resections: cost and value perspectives
18. Worldwide survey on opinions and use of minimally invasive pancreatic resection
19. Proceedings of the first international state-of-the-art conference on minimally-invasive pancreatic resection (MIPR)
20. Minimally invasive distal pancreatectomy
21. Standardizing terminology for minimally invasive pancreatic resection
22. Research considerations in the evaluation of minimally invasive pancreatic resection (MIPR)
23. ASO Visual Abstract: Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma
24. Laparoscopic parenchyma-sparing liver resection for colorectal metastases
25. Scandinavian multicenter study on the safety and feasibility of the associating liver partition and portal vein ligation for staged hepatectomy procedure
26. Response To “ALPPS Versus Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastases”
27. Laparoscopic liver resection for non-colorectal non-neuroendocrine metastases: perioperative and oncologic outcomes
28. Laparoscopic liver resection for metastatic melanoma
29. Margin status after laparoscopic resection of colorectal liver metastases: does a narrow resection margin have an influence on survival and local recurrence?
30. Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial
31. Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in a high rate of radical resections and long postoperative survival
32. Laparoscopic parenchyma-sparing liver resection for large (≥ 50 mm) colorectal metastases
33. Effect of TachoSil Patch in Prevention of Postoperative Pancreatic Fistula
34. Comparative evaluation of laparoscopic liver resection for posterosuperior and anterolateral segments
35. LAPAROSCOPIC LIVER RESECTION OF LESIONS IN THE POSTERIOR SEGMENTS USING AN ANTEROLATERAL APPROACH: EPL-25
36. LAPAROSCOPIC RIGHT HEPATECTOMY EXTENDED TO SEGMENT 4 A: ANTERIOR APPROACH: EPL-23
37. Additional file 1 of De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity
38. Additional file 2 of The expressed mutational landscape of microsatellite stable colorectal cancers
39. Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma
40. Aspirin as secondary prevention in colorectal cancer liver metastasis (ASAC trial) : study protocol for a multicentre randomized placebo-controlled trial
41. Implementation and training with laparoscopic distal pancreatectomy: 23-year experience from a high-volume center
42. Long-Term Oncologic Outcomes After Laparoscopic Versus Open Resection for Colorectal Liver Metastases
43. Genomic and prognostic heterogeneity among RAS/BRAFV600E/TP53 co‐mutated resectable colorectal liver metastases
44. Response to Comment on “ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM – It Is Time to Entry the IDEAL Stage 4?”
45. Genomic and Prognostic Heterogeneity Among RAS/BRAFV600E/TP53 Co-Mutated Resectable Colorectal Liver Metastases
46. Response to the Comment on “ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO—Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy”
47. ALPPS improves survival compared with TSH in patients affected of CRLM – Survival analysis from the randomized controlled trial LIGRO
48. Laparoscopic Liver Resection for Malignant and Benign Lesions: Ten-Year Norwegian Single-Center Experience
49. Changes in tonsillar tissue in early HIV-1 infection and during 3 years of antiretroviral therapy
50. Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.